Cystic kidney diseases that require a differential diagnosis from autosomal dominant polycystic kidney disease (ADPKD)

A Sekine, S Hidaka, T Moriyama, Y Shikida… - Journal of clinical …, 2022 - mdpi.com
Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary
cystic kidney disease, with patients often having a positive family history that is characterized …

[HTML][HTML] Patients with autosomal dominant polycystic kidney disease have elevated fibroblast growth factor 23 levels and a renal leak of phosphate

I Pavik, P Jaeger, AD Kistler, D Poster, F Krauer… - Kidney international, 2011 - Elsevier
Fibroblast growth factor 23 (FGF23) and parathyroid hormone blood levels rise following
progressive loss of renal function. Here we measured parameters of phosphate metabolism …

Soluble klotho and autosomal dominant polycystic kidney disease

I Pavik, P Jaeger, L Ebner, D Poster… - Clinical journal of the …, 2012 - journals.lww.com
Results ADPKD patients had 50% higher FGF23 levels than did XLH patients; TmP/GFR
was near normal in most ADPKD patients and very low in XLH patients. Serum Klotho levels …

Low-dose oral sirolimus and the risk of menstrual-cycle disturbances and ovarian cysts: analysis of the randomized controlled SUISSE ADPKD trial

M Braun, J Young, CS Reiner, D Poster, F Krauer… - 2012 - journals.plos.org
Sirolimus has been approved for clinical use in non proliferative and proliferative disorders.
It inhibits the mammalian target of rapamycin (mTOR) signaling pathway which is also …

The regulatory 1α subunit of protein kinase A modulates renal cystogenesis

H Ye, X Wang, MM Constans… - American Journal …, 2017 - journals.physiology.org
The failure of the polycystins (PCs) to function in primary cilia is thought to be responsible for
autosomal dominant polycystic kidney disease (ADPKD). Primary cilia integrate multiple …

A presumed synonymous mutation of PKD2 caused autosomal dominant polycystic kidney disease in a Chinese family

L Deng, Y Yang, J Yang, L Zhou, K Wang… - Current Medical Science, 2021 - Springer
Objective Autosomal dominant polycystic kidney disease (ADPKD) is mainly caused by the
pathogenic mutation of PKD1 or PKD2 gene and usually affects bilateral kidneys …

[PDF][PDF] Tratamiento eficaz de la arteriolopatía urémica calcificante con bifosfonatos

JV Torregrosa, CE Durán, X Barros, M Blasco… - Nefrología …, 2012 - SciELO Espana
TORREGROSA, José V. et al. Tratamiento eficaz de la arteriolopatía urémica calcificante
con bifosfonatos. Nefrología (Madr.)[online]. 2012, vol. 32, n. 3, pp. 329-334. ISSN 0211 …

Congenital solitary kidney in autosomal dominant polycystic kidney disease: Where do known genes end and the unknown begin?

R Bucci, F Tunesi, LI De Rosa, P Carrera… - Clinical Case …, 2023 - Wiley Online Library
Key Clinical Message We present the case of a 41‐year‐old man patient diagnosed with
solitary left kidney with few cysts. He has a family history of unilateral renal agenesis (URA) …

Autosomal dominant polycystic kidney disease with ectopic unilateral multicystic dysplastic kidney

J Xu, DP Chen, ZG Mao, HF Huang, CM Xu, CR Wang… - BMC nephrology, 2013 - Springer
Background Autosomal dominant polycystic kidney disease (ADPKD) is the most common
hereditary renal disorder. In most cases, ADPKD similarly affects bilateral kidneys. Case …

[HTML][HTML] A comparison of the effects of losartan and ramipril on blood pressure, renal volume and progression in polycystic kidney disease: A 5-Year follow-up

S Ulusoy, G Ozkan, P Kosucu, K Kaynar, I Eyuboglu - Hippokratia, 2012 - ncbi.nlm.nih.gov
Background: The major cause of hereditary renal failure is autosomal dominant polycystic
kidney disease (ADPKD). Many factors affect renal progression in these patients. Among …